The largest database of trusted experimental protocols
> Disorders > Disease or Syndrome > Cauda Equina Syndrome

Cauda Equina Syndrome

Cauda Equina Syndrome: A serious condition involving compression or injury to the bundle of nerves at the base of the spinal cord, the cauda equina.
Symptoms may include lower back pain, numbness, weakness, or incontinence.
Early diagnosis and treatment are crucial to prevent permanent neurological damage.
Explore the latest research on effective management strategies using PubCompare.ai's AI-powered platform, which can help you locate and compare relevant protocols from literature, preprints, and patents.
Streamline your cauda equina syndrome research and find the best approaches for your needs.

Most cited protocols related to «Cauda Equina Syndrome»

We prospectively evaluated the association between the diagnosis of LSS and clinical information, including the history and physical examination of patients with leg symptoms. This study was performed in six university hospitals, ten medical centers, and sixty eight hospitals and clinics affiliated with university hospitals or medical centers during July and September in 2004. We enrolled consecutive patients older than 20 years of age with primary symptoms of pain or numbness in the legs. We excluded patients who have been treated by some medical practices within one year before examination. Patients with cervical myelopathy, previous surgery, degenerative scoliosis (defined as lateral tilting of more than 10 degrees) and inflammatory disorders were also excluded. This study included 250 patients who complained of leg symptoms, including cases of LSS (n = 165), lumbar disc herniation (n = 61), diabetic neuropathy (n = 13), and peripheral vascular disease (n = 11) (Table 3). The study was approved by the institutional review board of each study institution as necessary. Written informed consent was obtained from the all patients. The patients gave informed consent and then answered the SSHQ. The following steps were taken to reach a final diagnosis for each of the enrolled patients (Figure 1). In the first step, at each institution the orthopedic physician who saw a patient made the clinical diagnosis based on the history, physical examination, and radiographic findings. In addition, to verify the diagnosis made by each physician, six board-certified spine surgeons approved by the Japanese Board of Spine Surgery also made a diagnosis for each patient based on the clinical information and findings of the MRI. The opinions of six board-certified spine surgeons approved by the Japanese Board of Spine Surgery were used as the gold standard for diagnosis of LSS. The radicular type was characterized by symptoms of pain, burning, numbness, and paresthesias following a specific dermatome with radiological evidence of the responsible nerve root compression, which was confirmed if intermittent claudication was abolished following single nerve root infiltration. Patients of the cauda equina type presented some bilateral symptoms related to cauda equina compression syndrome with less dermatomal-specific neurogenic claudication and radiological evidence of cauda equina compression.
The sensitivity, specificity, likelihood ratio, and area under the receiver operating characteristic (ROC) curve were estimated. 217 patients classified by investigators as suffering from lower back pain without a significant change in symptoms were given the SSHQ two weeks later during an outpatient visit, and the test-retest reliability over two weeks was investigated in these patients.
Full text: Click here
Publication 2007
Cauda Equina Cauda Equina Syndrome Diabetic Neuropathies Diagnosis Ethics Committees, Research Gold Hypersensitivity Inflammation Intermittent Claudication Intervertebral Disk Displacement Japanese Low Back Pain Lumbar Region Neck Nerve Root Compression Nervousness Neurogenesis Operative Surgical Procedures Outpatients Pain Paresthesia Patients Peripheral Vascular Diseases Physical Examination Physicians Scoliosis Spinal Cord Diseases Surgeons Tooth Root Vertebral Column X-Rays, Diagnostic
The eligibility criteria for study selection used in this review are summarised in Table 1. Titles were initially screened by one reviewer (SS). When eligibility could not be determined on the basis of the title, abstracts were reviewed. To select full text papers, two reviewers (SS, KK) independently screened titles and abstracts of the remaining citations. Any disagreements were resolved through discussion and consensus. Selected full text papers and additional papers identified in reference lists of the included full text papers were screened by the same two reviewers and final agreement was reached on which papers to be included in the review.

Study eligibility criteria

Published studies were included if they fulfilled any of the following criteria:
 • Developed and described an original classification system for back pain that included adult patients with low back related leg pain (LBLP). Leg pain was defined as pain below the gluteal fold. • Adapted an existing classification system that was designed for or included LBLP patients. • Provided approaches to appraising or validating an existing classification system for LBLP.
Exclusion criteria:
 • Studies looking at specific spinal “red flag” conditions such as cauda equina syndrome, tumours or spinal fractures or a specific disease cohort such as diabetes. • Studies that only used expensive or advanced investigations or technology more likely to be feasible for secondary care settings (e.g. electromyography, surgical findings, imaging or expensive kinematic equipment) for classification of patients. • Case studies and case series design studies.
Full text: Click here
Publication 2016
Adult Back Pain Buttocks Cauda Equina Syndrome Diabetes Mellitus Electromyography Eligibility Determination Low Back Pain Neoplasms Operative Surgical Procedures Pain Patients Secondary Care Spinal Fractures Training Programs
A convenience sample of 20 LBP subjects (mean ±SD age = 28.83 ±11.13 years, height = 166.83
±12.50 cm, weight = 61.17 ±9.60 kg, duration = 13.65 ±10.24 months) volunteered for this
study at a local orthopedic clinic. Subjects had pain scores ranging from 5 –7 on a visual
analogue scale, and scores of 40–60% on the Korean version of the Oswestry disability index.
LBP was defined as current symptoms of pain and/or numbness between the twelfth rib and
buttocks with or without symptoms in one or both legs that limited function9 (link)). Participants were excluded if they had
received lumbar surgery were unable to lie prone or supine for a minimum of 20 minutes or
presented with potentially serious conditions such as cauda equina syndrome, major or
rapidly progressing neurologic deficit, fracture, cancer, infection, or systemic
diseases.
This study used ADIM to draw in and hold the lower abdomen at maximum expiration in a
supine position. Verbal instructions for the ADIM were “Draw your belly inward and upward
while breathing normally, then hold the contraction for 10 seconds.” ADIM was performed 3
times, with 10 second rest periods10 ).
Before progressing to the main experiment, the subjects were educated in the method of ADIM
and practiced 3 sets to decrease errors arising from incorrect performance.
Rest and ADIM thicknesses of the TrA, IO and EO were obtained using a LOGIQ P5(GE
Healthcare, USA) with a 7.5-MHz linear probe. Conductive gel was placed between the
transducer and subjects skin. The measurements were taken as described by Richardson et al.
with the subjects in the supine hook lying position with the transducer placed just superior
to the iliac crest along the axillary line11 ). The transducer head location was marked on the right-hand side of
each subject midway between the lowest rib and the apex of the ilium. This has been shown to
be the thickest point of the Tra, and demonstrates the clearest simultaneous images of Tra,
IO and EO12 ). The thickness of each of the
3 muscles (TrA, IO, and EO muscles) was measured at the center line of the image.
The average of the 3 trials was used in the analysis. In processing data, the version 12.0
program was used. In order to assess the intra-examiner and inter-examiner of the ultrasound
imaging intra class coefficients (ICC) were computed.
Publication 2013
Abdomen Axilla Cauda Equina Syndrome Disabled Persons Electric Conductivity Fracture, Bone Head Iliac Crest Ilium Infection Koreans Leg Lumbar Region Malignant Neoplasms Muscle Tissue Operative Surgical Procedures Pain Skin Transducers Venous Catheter, Central
The inclusion and exclusion criteria are listed in Table 1. Volunteers between the ages of 21 and 65 years with acute, sub-acute or chronic low back pain who are willing and able to sign informed consent documents are eligible for this study. Participants must also have a numerical pain rating scale (NRS) greater than or equal to 4 (on a scale of 0 - 10) at either the initial computer assisted telephone interview (CATI ) or the baseline 1 in-person interview. In addition, NRS measurements cannot be less than 2 at any screening visit.
Exclusion criteria have been developed to screen out patients with: safety concerns for either SM or the sensorimotor testing (e.g. bleeding disorders, sensitivity to tape, contra-indication to SM, pregnancy); unconfirmed safety (e.g. joint replacement, pacemaker); safety concern related to equipment weight capacity (e.g. extreme obesity with weight greater than or equal to 307 pounds); conditions that may result in intolerance to biomechanical testing or treatment protocols (e.g. vascular claudication, bone and joint abnormality, inflammatory or destructive tissue changes to the spine, osteoporosis, Quebec Task Force classification 4, 5, 6, 8, 9, 10, 11 [73 (link)]); overall condition too poor to tolerate treatment and biomechanical testing procedures; conditions that may interfere with data collection (e.g. neuromuscular diseases, peripheral neuropathies, prior spinal surgery); conditions that might interfere with data collection and ability to comply with study protocol (e.g. suspicion of drug or alcohol abuse, uncontrolled hypertension, depression according to the Beck Depression Inventory-II©); condition which requires surgical evaluation (e.g. cauda equina syndrome); and other concerns which may make it difficult to fully consent, interfere with study compliance, or constitute a possible data confounder (e.g. inability to read or verbally comprehend English), indicators for diagnostic procedures beyond dipstick urinalysis or x-rays, retention of legal advice for an open or pending case related to LBP and ongoing treatment for LBP by other health care providers.
Full text: Click here
Publication 2011
Abuse, Alcohol Arthroplasty, Replacement Blood Coagulation Disorders Blood Vessel Bones Cauda Equina Syndrome High Blood Pressures Hypersensitivity Inflammation Joints Low Back Pain Melancholia Neuromuscular Diseases Obesity Operative Surgical Procedures Osteoporosis Outpatients Pacemaker, Artificial Cardiac Pain Pain Measurement Peripheral Nervous System Diseases Pharmaceutical Preparations Pregnancy Retention (Psychology) Safety Tests, Diagnostic Tissues Treatment Protocols Urinalysis Vertebral Column Voluntary Workers X-Rays, Diagnostic
Both pre-operative and surgical inclusion/exclusion criteria have been established for this trial. Specifically, the study will recruit participants with symptomatic herniated NP unresponsive to nonoperative care and considered candidates for nerve decompression and surgical excision of the herniated lumbar IVD fragments [1 (link)]. Clinical signs and symptoms, as well as magnetic resonance imaging (MRI) findings must corroborate the diagnosis of lumbar IVD herniation. Patients with previous lumbar surgery will not be considered for this trial. Furthermore, only patients who receive single-level discectomy will be considered eligible to receive UPAL gel implantation.
Upon completion of standard discectomy, the treating surgeon will assess the feasibility of AF re-approximation and make the final decision whether the patient will receive UPAL gel implantation and be officially enrolled in the study [1 (link)]. The complete inclusion/exclusion criteria are as follows [1 (link)].
Inclusion criteria.

Candidate for lumbar discectomy.

Radiographic findings corroborating symptoms of IVD herniation.

Condition unresponsive to 6 consecutive weeks of therapy or experiencing acute/uncontrolled leg pain, defined as a score >80 on the 100-mm visual analog scale (VAS), in which higher scores representing worse pain correspond to worse pain.

Single-level lumbar IVD herniation.

Persistent and predominant leg pain (score >40 on the 100-mm VAS)

Age between 20 and 49 years (inclusively).

Willingness to provide written informed consent, fill in all necessary questionnaires, and return for follow-up.

Exclusion criteria.

Previous surgery involving a lumbar level.

Prior or planned spinal fusion involving a lumbar level.

Local kyphosis involving the affected disc level, evident on plain radiography of the lumbar spine in the flexion, neutral or extension position.

Spondylolisthesis or retrolisthesis above grade 1 at the affected level.

Cauda equina syndrome.

Acute local or systemic infection.

Active malignancy or other similar comorbidities.

Current drug or alcohol dependency.

Current significant emotional disturbance.

Current fracture, tumour, and/or deformity of the lumbar spine.

Current or planned pregnancy.

Currently enrolled in other research that could confound the results of the present trial.

Presence of a metal implant or any other contraindication to MRI.

Allergy to sodium alginate revealed upon skin prick testing.

Any other reason judged by an investigator or clinical trial doctor to render the candidate unsuitable for this clinical trial.

Eligible candidates will be treated at the Hokkaido University Hospital in Sapporo, Japan, or at Eniwa Hospital in Eniwa, Japan, depending on where the referring orthopaedic surgeons have formal accreditation. The treatment will include discectomy followed by UPAL gel implantation. The discectomy procedure is part of the accepted standard treatment of each participant but is not part of the present study. The discectomies will be performed by the referring surgeons and will not be performed by a single surgeon.
Full text: Click here
Publication 2021
Alcoholic Intoxication, Chronic Cauda Equina Syndrome Congenital Abnormality Decompression Diagnosis Diskectomy Emotional Disturbances Fracture, Bone Hernia Hypersensitivity Kyphosis Lumbar Region Malignant Neoplasms Metals Neoplasms Nervousness Operative Surgical Procedures Orthopedic Surgeons Ovum Implantation Pain Pains, Acute Patients Pharmaceutical Preparations Physicians Sepsis Sodium Alginate Spinal Fusions Spondylolisthesis Surgeons Vertebrae, Lumbar Visual Analog Pain Scale X-Rays, Diagnostic

Most recents protocols related to «Cauda Equina Syndrome»

After approval by the ethics committee in our hospital, a retrospective review of 247 consecutive patients who were diagnosed with DLS between January 2019 and December 2021 was performed. All patients were recruited from outpatient spinal surgery clinics and scheduled to undergo spine surgery. 3D printing molds are used for preoperative planning and surgical simulation.
The inclusion requirements included: (1) L4 DLS; (2) Meyerding grade I or II; and (3) complete radiographic data, including whole-spine anteroposterior and lateral radiographs and lateral flexion and extension X-ray of the lumbar spine.
The exclusion criteria were as follows: (1) multilevel DLS; (2) isthmic spondylolisthesis; (3) history of prior lumbar trauma, tumor, infection, cauda equina syndrome, or revision surgery; and (4) surgery requiring more than two-level instrumentation and fusion.
Demographic data were collected using electronic medical record reviews, including age, gender, height, weight, and body mass index. Overall, 101 patients were ultimately enrolled in the present study.
Full text: Click here
Publication 2023
Cauda Equina Syndrome Ethics Committees Fungus, Filamentous Gender Historical Trauma Index, Body Mass Infection Lumbar Region Neoplasms Operative Surgical Procedures Patients Radiography Repeat Surgery Spondylolisthesis Vertebrae, Lumbar Vertebral Column
Multiple village-wide announcements facilitated by village/ward heads (traditional rulers) and adverts via local posters pasted at the research centre and different locations in the community were used to recruit participants until the target sample size was achieved. Potential participants were invited to the primary health care centre and upon their arrival, eligibility was ensured using the stipulated study inclusion and exclusion criteria. The eligibility assessments were carried out by physiotherapists with the use of body charts to identify pain in the lower back, history taking, and screening to rule out ‘red flags’ for low back pain [56 (link)]. All participants provided written informed consent. Inclusion criteria were as follows: (1) male or female between the age of 18 and 70 years, (2) nonspecific low back pain with or without leg pain experienced for 12 weeks or more, and (3) ability to read and understand Hausa or English language or both. Exclusion criteria were: (1) history of spine surgery, (2) obvious spine or limb deformities, (3) serious spinal pathology (e.g. infection, metastases, cauda equina syndrome, and fracture) (4) unstable or severe disabling chronic cardiovascular and pulmonary diseases, (5) inadequate visual and hearing ability, (6) previous physiotherapy treatment in the form of exercise and/or education in the last 3 months, (7) body mass index (BMI) ≥ 35 kg/cm2, and (8) pregnancy. Verbal information about the study purpose and potential benefits using an information sheet was read to the eligible participants. Those willing to participate were then given a written informed consent form to sign or make a thumbprint.
Full text: Click here
Publication 2023
Back Pain Cardiovascular System Cauda Equina Syndrome Congenital Abnormality Eligibility Determination Fracture, Bone Head Human Body Index, Body Mass Infection Low Back Pain Lung Diseases Males Neoplasm Metastasis Operative Surgical Procedures Pain Physical Therapist Pregnancy Primary Health Care Therapies, Exercise Vertebral Column Woman
After approval by the ethics committee at our hospital, a retrospective review was performed of 279 consecutive patients diagnosed with DLSS between January 2018 and August 2020. The inclusion requirements necessitated that patients were [7 (link), 12 (link)] 1) aged 40–80 years and 2) underwent ICS and transforaminal lumbar interbody fusion (TLIF), 3) with a minimum follow-up of 12 months. The exclusion criteria included 1) previous spinal surgery, 2) osteopenia or osteoporosis, 3) degenerative lumbar scoliosis (Cobb angle > 25°), 4) cauda equina syndrome, 5) spinal infection, and 6) radiographically confirmed damage of the vertebrae caused by trauma or tumors. A total of 89 patients were included in the final analysis after selection.
Demographic data, such as age, sex, height, weight, and body mass index (BMI), were collected via electronic medical record reviews. The bone mineral density (BMD) at the lumbar spine was assessed via dual-energy X-ray absorptiometry.
The patients were classified into three groups based on the fusion levels. Patients with L5-S1 TLIF and ICS at L4-L5 were assigned to Group A, patients with L4-S1 TLIF and ICS at L3-L4 were assigned to Group B, and those with L3-S1 TLIF and ICS at L2-L3 were assigned to Group C.
Full text: Click here
Publication 2023
Bone Density Cauda Equina Syndrome Dual-Energy X-Ray Absorptiometry Ethics Committees Index, Body Mass Infection Lumbar Region Neoplasms Operative Surgical Procedures Osteopenia Osteoporosis Patients Scoliosis Vertebra Vertebrae, Lumbar Wounds and Injuries
This prospective observational study was approved by the Institutional Review Board of the author’s hospital and registered with the WHO International Clinical Trials Registry Platform (KCT0006046). This manuscript adheres to the applicable STROBE guidelines. After obtaining written informed consent, a total of 72 consecutive patients who visited our pain clinic in a tertiary care hospital due to LSS were enrolled in the study. Inclusion criteria were as follows: (1) age >40 years; (2) clinical LSS symptoms (radiculopathy +/− low back pain) more than 3 months; (3) symptom intensity with numeric rating scale (NRS; 0–10) of 4 or more; (4) radiologic confirmation of LSS through magnetic resonance imaging (MRI). Patients with a literacy problem or language difficulties; a history of psychotic disorder or drug abuse; chronic opioid usage over 3 months; a concomitantly complicated spinal disease, including epidural lipomatosis; ligament ossification or diffuse idiopathic skeletal hyperostosis; a definite indication for prompt surgery, such as cauda equina syndrome; a history of previous spinal surgery; orthopedic metal implants in any body region; and cardiac pacemaker or implantable cardioverter-defibrillator (ICD) were excluded from the study.
Full text: Click here
Publication 2023
Body Regions Cauda Equina Syndrome Drug Abuse Ethics Committees, Research Hyperostosis, Diffuse Idiopathic Skeletal Implantable Defibrillator Ligaments Lipomatosis, Multiple Symmetrical Low Back Pain Metals Operative Surgical Procedures Opioids Osteogenesis Pacemaker, Artificial Cardiac Patients Psychotic Disorders Radiculopathy Spinal Diseases
This is a retrospective observational study carried out at the Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine (Jiangsu, China) from March 2011 to June 2020. Eight patients with giant tumor-like LDH who had resorption after non-surgical treatment formed the basis of this study. The clinical data, including clinical symptoms, MRI images, Japanese orthopaedic association (JOA) score before and after treatment, “bull’s eye” sign classification, follow-up time, time of resorption and other clinical data were collected from case notes. According to the clinical symptoms and MRI imaging findings, these 8 patients were diagnosed as giant tumor-like LDH. We adopted a non-surgical treatment plan for the patients, including taking oral non-steroidal anti-inflammatory agents and performing rehabilitation exercise. In consideration of the risk of irreversible neurological damage which could be caused by long-term non-surgical treatment, patients are closely observed during treatment and follow-up. Once the following conditions occur, surgical treatment is required immediately [8 (link)]: The symptoms are not signifcantly relieved after 3 to 6 months of non-surgical treatment; The symptoms are aggravated by non-surgica treatment; The clinical manifestations of cauda equina syndrome.
Full text: Click here
Publication 2023
Aftercare Anti-Inflammatory Agents, Non-Steroidal Cauda Equina Syndrome Chinese Gigantism Japanese Long-Term Care Neoplasms Operative Surgical Procedures Patients Pharmaceutical Preparations Therapies, Exercise Trauma, Nervous System

Top products related to «Cauda Equina Syndrome»

More about "Cauda Equina Syndrome"

Cauda Equina Syndrome (CES) is a serious neurological condition characterized by compression or injury to the bundle of nerves at the base of the spinal cord, known as the cauda equina.
This condition can lead to a range of debilitating symptoms, including lower back pain, numbness, weakness, and incontinence.
Early diagnosis and prompt treatment are crucial to prevent permanent neurological damage and long-term complications.
CES is considered a medical emergency, as the compressed or injured nerves can quickly lead to irreversible nerve damage if left untreated.
The condition may be caused by a variety of factors, such as spinal disc herniation, spinal stenosis, tumors, or traumatic injury to the spine.
Symptoms of CES can vary depending on the severity and location of the nerve compression.
Common signs include lower back pain, bilateral leg pain or weakness, numbness or tingling in the groin, buttocks, or legs, and bladder or bowel dysfunction.
In severe cases, patients may experience complete paralysis of the lower extremities and loss of bowel and bladder control.
Effective management of CES requires a multidisciplinary approach, involving early surgical decompression to relieve the nerve pressure, as well as rehabilitation and supportive care.
Researchers are continuously exploring new treatment strategies, including the use of pharmacological interventions, regenerative therapies, and advanced imaging techniques to improve patient outcomes.
PubCompare.ai's AI-powered platform can be a valuable tool for researchers and clinicians working in the field of CES.
The platform allows users to locate and compare relevant protocols from the literature, preprints, and patents, streamlining the research process and helping to identify the most effective management approaches for their specific needs.
By leveraging the latest advancements in artificial intelligence, PubCompare.ai can help accelerate the development of better treatments and improve the care of patients with this devastating condition.